Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
13.46
+0.32 (2.44%)
Aug 10, 2026, 2:05 PM EDT - Market open

Alpha Tau Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-46.29-42.29-36.04-35.68-32.14-13.79
Net Income
-56.88-42.63-31.75-29.16-33.76-27.27
Earnings Per Share
-0.67-0.53-0.45-0.42-0.53-0.67
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
76.4273.1359.681.79104.5331.32
Total Debt
14.3413.7312.5413.285.190
Net Cash (Debt)
62.0859.447.0668.5199.3431.32
Net Cash Growth
57.79%26.21%-31.30%-31.03%217.21%-31.94%
Net Cash Per Share
0.730.740.670.991.560.77

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.68-26.68-19.78-17.96-23.88-11.81
Capital Expenditures
-6.08-6.08-2.24-6.4-0.9-2.93
Free Cash Flow
-32.76-32.76-22.02-24.36-24.78-14.74
Free Cash Flow Growth
------